D.A. Wallach

D.A. Wallach, a General Partner at Time BioVentures, focuses on biotech and machine learning. Matt Turck from FirstMark specializes in enterprise software and AI. Astasia Myers of Felicis invests in early-stage AI and cybersecurity. They discuss the biotech sector's struggle amidst a tough market, contrasting it with the booming AI landscape. Virtual doctors and advancements in fertility tech have the potential to revolutionize healthcare. The panel also explores investment trends and the democratization of AI tools—shaping the future of startups.

D.A. Wallach, an investor, musician, and writer, shares insights on the intersection of creativity and technology. He discusses engineered serendipity through cold emailing and the complexities of biotech investments like CRISPR. D.A. delves into the balance of market innovation and healthcare rights, highlighting AI's potential to empower patients. He reflects on the role of beauty in art and urges artists to reclaim their influence. With his diverse experiences, D.A. inspires listeners to embrace curiosity and interdisciplinary collaboration.

D.A. Wallach, co-founder of Time BioVentures and former lead singer of Chester French, shares his unique journey from music to biotech investing. He discusses the complexities of biotech, comparing it to a 'bag of options' with long timelines. Wallach emphasizes the importance of experienced founders and the challenges of clinical trials as major bottlenecks. He also tackles the impact of AI on drug discovery, the rise of China's biotech sector, and the nuances of patient autonomy, all while hinting at how music and biotech intersect.

D.A. Wallach, former lead singer of Chester French and artist-in-residence at Spotify, shares his journey from music to healthcare investing. He discusses how advancements in personalized medicine and genetic therapies are revolutionizing treatment options. Wallach dives into the potential of CRISPR technology and the ethics surrounding gene editing, as well as the complexities of drug pricing in today's healthcare system. He emphasizes the importance of informed choices in healthcare investments and the transformative role of technology in personal health.

In this episode, Dan Rasmussen, founder of Verdad Advisers, and D.A. Wallach, a venture investor and musician, dive into the exciting world of biotech and healthcare. They discuss the transformative impact of AI and emerging treatments like gene therapy on patient care. The duo shares insights on private equity dynamics and investment strategies, especially in the context of rising interest rates. They also touch on global market trends and Japan's corporate reforms, highlighting unique investment opportunities in the evolving landscape.

D.A. Wallach, a venture capitalist at Time BioVentures and former frontman of Chester French, dives into the murky waters of healthcare ethics. He draws fascinating parallels between music and medicine, questioning outdated titles like 'doctor' and advocating for AI's role in patient care. With a focus on the need for a universal, evidence-based standard of care, he critiques the current profit-driven systems and urges a reevaluation of healthcare relationships. Wallach's insights promise a provocative peek into a future where compassion meets innovation.

D.A. Wallach, co-founder of Time BioVentures and former recording artist, shares his intriguing journey from touring with stars like Lady Gaga to investing in life sciences. He discusses how his experiences in the music industry shaped his investment philosophy. The conversation covers the intersection of creativity and technology, tackling healthcare reform, and the role of AI in drug discovery. Wallach emphasizes the importance of taste in investment decisions, highlighting the need for innovation within the healthcare system.

D.A. Wallach, a musician turned investor and founder of TimeBio Ventures, joins the discussion to explore the intriguing intersection of music and biotech investing. He reflects on the evolving music industry in the digital age and emphasizes the need for artists to innovate. The conversation also dives into the complexities of healthcare investments, touching on ethical concerns in genetic technology. Additionally, they discuss Spotify's massive naming rights deal for FC Barcelona and AMC's surprising foray into gold mining, blending humor with sharp insights on market dynamics.

D.A. Wallach, a visionary at the intersection of music and medicine, shares insights into the healthcare sector's slow adoption of technological advancements. He discusses the staggering contrasts between healthcare and more innovative industries. Wallach highlights the potential of biotechnology to revolutionize medicine and emphasizes the importance of personalized care in enhancing longevity. He addresses the significant challenges of cost, quality, and access within healthcare, stressing the need for emerging technologies to bridge these critical gaps.

D.A. Wallach is a true polymath: recording artist, songwriter, essayist, investor, and so much more. In this episode, among the highlights, D.A. provides compelling and colorful insight into how the music industry works today vs the past, liquid biopsies, how to approach healthspan, cancer screening, and how we can reach a "singularity" in medicine. We discuss: How to learn music as a kid and an adult [7:30]; Chester French's early struggles and ultimate success [16:45]; Learning to learn, fostering curiosity in kids, and balancing creativity with structure [31:30]; D.A.'s musical inspirations [44:30]; History of the music industry, Spotify, and other disruptive technologies [50:00]; The past, present, and future of medicine, hospitals, and healthcare [1:05:30]; Investing in health [1:16:30]; What D.A. is most excited about in the future of medicine [1:22:00]; Liquid biopsies, how to make sense of the morass of sensitivity, specificity, positive predictive value, negative predictive value, true negatives, false positives, false negatives, and true positives in cancer screening...and the swiss cheese metaphor [1:33:00]; The immune system, inflammation, and allergies [2:05:45]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on Facebook | Twitter | Instagram.